首页 | 本学科首页   官方微博 | 高级检索  
     


A Potent,Selective and Cell‐Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)
Authors:H. Ü  mit Kaniskan,Magdalena M. Szewczyk,Zhengtian Yu,Mohammad S. Eram,Xiaobao Yang,Keith Schmidt,Xiao Luo,Miao Dai,Feng He,Irene Zang,Ying Lin,Steven Kennedy,Fengling Li,Elena Dobrovetsky,Aiping Dong,David Smil,Sun‐Joon Min,Melissa Landon,Jennifer Lin‐Jones,Xi‐Ping Huang,Bryan L. Roth,Matthieu Schapira,Peter Atadja,Dalia Barsyte‐Lovejoy,Cheryl H. Arrowsmith,Peter J. Brown,Kehao Zhao,Jian Jin,Masoud Vedadi
Abstract:PRMT3 catalyzes the asymmetric dimethylation of arginine residues of various proteins. It is essential for maturation of ribosomes, may have a role in lipogenesis, and is implicated in several diseases. A potent, selective, and cell‐active PRMT3 inhibitor would be a valuable tool for further investigating PRMT3 biology. Here we report the discovery of the first PRMT3 chemical probe, SGC707, by structure‐based optimization of the allosteric PRMT3 inhibitors we reported previously, and thorough characterization of this probe in biochemical, biophysical, and cellular assays. SGC707 is a potent PRMT3 inhibitor (IC50=31±2 nM , KD=53±2 nM ) with outstanding selectivity (selective against 31 other methyltransferases and more than 250 non‐epigenetic targets). The mechanism of action studies and crystal structure of the PRMT3‐SGC707 complex confirm the allosteric inhibition mode. Importantly, SGC707 engages PRMT3 and potently inhibits its methyltransferase activity in cells. It is also bioavailable and suitable for animal studies. This well‐characterized chemical probe is an excellent tool to further study the role of PRMT3 in health and disease.
Keywords:Allosterische Inhibierung  Chemische Sonden  Enzyminhibitoren  Histonmethylierung    ntgenbeugung
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号